Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Duncan

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Blood Advances|September 18, 2025
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 yearsAnna C Ferreira, Debjani Dutta, Courtney M Rowan, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 8, 2021
Candidacy for Extracorporeal Life Support in Children After Hematopoietic Cell Transplantation: A Position Paper From the Pediatric Acute Lung Injury and Sepsis Investigators Network's Hematopoietic Cell Transplant and Cancer Immunotherapy SubgroupMatt S Zinter, Jennifer McArthur, Christine Duncan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2017
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCTJennifer Heimall, Jennifer Puck, Rebecca Buckley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2017
Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell TransplantationShalini Shenoy, Emanuele Angelucci, Staci D Arnold, et al.
Blood Advances|August 21, 2023
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host diseaseHolly Wobma, Malika Kapadia, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 9, 2017
Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCTJennifer Heimall, Rebecca H Buckley, Jennifer Puck, et al.
Blood|January 24, 2020
Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groupsCourtney M Rowan, Francis Pike, Kenneth R Cooke, et al.
Nature Communications|April 5, 2023
Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophyArne Lauer, Samantha L Speroni, Myoung Choi, et al.
Transplantation and Cellular Therapy|April 26, 2026
Eculizumab for Pediatric Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy: Real World Response Rates, Predictors of Poor Response, and an Optimal Timepoint for Treatment Response AssessmentMichelle L Schoettler, Geoffrey Cheng, Christine S Higham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2019
Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) RegistriesMatt S Zinter, Brent R Logan, Caitrin Fretham, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Blood Advances|September 18, 2025
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 yearsAnna C Ferreira, Debjani Dutta, Courtney M Rowan, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 8, 2021
Candidacy for Extracorporeal Life Support in Children After Hematopoietic Cell Transplantation: A Position Paper From the Pediatric Acute Lung Injury and Sepsis Investigators Network's Hematopoietic Cell Transplant and Cancer Immunotherapy SubgroupMatt S Zinter, Jennifer McArthur, Christine Duncan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2017
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCTJennifer Heimall, Jennifer Puck, Rebecca Buckley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2017
Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell TransplantationShalini Shenoy, Emanuele Angelucci, Staci D Arnold, et al.
Blood Advances|August 21, 2023
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host diseaseHolly Wobma, Malika Kapadia, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 9, 2017
Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCTJennifer Heimall, Rebecca H Buckley, Jennifer Puck, et al.
Blood|January 24, 2020
Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groupsCourtney M Rowan, Francis Pike, Kenneth R Cooke, et al.
Nature Communications|April 5, 2023
Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophyArne Lauer, Samantha L Speroni, Myoung Choi, et al.
Transplantation and Cellular Therapy|April 26, 2026
Eculizumab for Pediatric Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy: Real World Response Rates, Predictors of Poor Response, and an Optimal Timepoint for Treatment Response AssessmentMichelle L Schoettler, Geoffrey Cheng, Christine S Higham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2019
Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) RegistriesMatt S Zinter, Brent R Logan, Caitrin Fretham, et al.
Pageof 5